Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPensionProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMCQF) Finished Goods (2016 - 2025)

Fresenius Medical Care AG has reported Finished Goods over the past 17 years, most recently at $1.5 billion for Q4 2025.

  • Quarterly results put Finished Goods at $1.5 billion for Q4 2025, up 15.3% from a year ago — trailing twelve months through Dec 2025 was $1.5 billion (up 15.3% YoY), and the annual figure for FY2025 was $1.5 billion, up 15.3%.
  • Finished Goods for Q4 2025 was $1.5 billion at Fresenius Medical Care AG, up from $1.3 billion in the prior quarter.
  • Over the last five years, Finished Goods for FMCQF hit a ceiling of $1.5 billion in Q4 2025 and a floor of $1.3 billion in Q4 2024.
  • Median Finished Goods over the past 5 years was $1.3 billion (2022), compared with a mean of $1.4 billion.
  • Biggest five-year swings in Finished Goods: dropped 5.19% in 2022 and later rose 15.3% in 2025.
  • Fresenius Medical Care AG's Finished Goods stood at $1.4 billion in 2021, then decreased by 5.19% to $1.3 billion in 2022, then decreased by 0.84% to $1.3 billion in 2023, then fell by 4.76% to $1.3 billion in 2024, then increased by 15.3% to $1.5 billion in 2025.
  • The last three reported values for Finished Goods were $1.5 billion (Q4 2025), $1.3 billion (Q4 2024), and $1.3 billion (Q4 2023) per Business Quant data.